The Clinical Global Impression Scale and the influence of patient or staff perspective on outcome - PubMed (original) (raw)
Clinical Trial
The Clinical Global Impression Scale and the influence of patient or staff perspective on outcome
Thomas Forkmann et al. BMC Psychiatry. 2011.
Abstract
Background: Since its first publication, the Clinical Global Impression Scale (CGI) has become one of the most widely used assessment instruments in psychiatry. Although some conflicting data has been presented, studies investigating the CGI's validity have only rarely been conducted so far. It is unclear whether the improvement index CGI-I or a difference score of the severity index CGI-S (dif) is more valid in depicting clinical change. The current study examined the validity of these two measures and investigated whether therapists' CGI ratings correspond to the view the patients themselves have on their condition.
Methods: Thirty-one inpatients of a German psychotherapeutic hospital suffering from a major depressive disorder (age M = 45.3, SD = 17.2; 58.1% women) participated. Patients filled in the Beck Depression Inventory (BDI). CGI-S and CGI-I were rated from three perspectives: the treating therapist (THER), the team of therapists involved in the patient's treatment (TEAM), and the patient (PAT). BDI and CGI-S were filled in at admission and discharge, CGI-I at discharge only. Data was analysed using effect sizes, Spearman's ρ and intra-class correlations (ICC).
Results: Effect sizes between CGI-I and CGI-S (dif) ratings were large for all three perspectives with substantially higher change scores on CGI-I than on CGI-S (dif). BDI (dif) correlated moderately with PAT ratings, but did not correlate significantly with TEAM or THER ratings. Congruence between CGI-ratings from the three perspectives was low for CGI-S (dif) (ICC = .37; Confidence Interval [CI] .15 to .59; F(30,60) = 2.77, p < .001; mean ρ = 0.36) and moderate for CGI-I (ICC = .65 (CI .47 to .80; F(30,60) = 6.61, p < .001; mean ρ = 0.59).
Conclusions: Results do not suggest a definite recommendation for whether CGI-I or CGI-S (dif) should be used since no strong evidence for the validity of neither of them could be found. As congruence between CGI ratings from patients' and staff's perspective was not convincing it cannot be assumed that CGI THER or TEAM ratings fully represent the view of the patient on the severity of his impairment. Thus, we advocate for the incorporation of multiple self- and clinician-reported scales into the design of clinical trials in addition to CGI in order to gain further insight into CGI's relation to the patients' perspective.
Figures
Figure 1
Effect sizes between CGI-I and CGI-Sdif for the perspectives patient (PAT), therapist (THER) and team of therapists concerned with the patient (TEAM). Higher scores indicate greater change between admission and discharge.
Similar articles
- A Characterization of the Clinical Global Impression Scale Thresholds in the Treatment of Adolescent Depression Across Multiple Rating Scales.
Zhang CY, Voort JLV, Yuruk D, Mills JA, Emslie GJ, Kennard BD, Mayes T, Trivedi M, Bobo WV, Strawn JR, Athreya AP, Croarkin PE. Zhang CY, et al. J Child Adolesc Psychopharmacol. 2022 Jun;32(5):278-287. doi: 10.1089/cap.2021.0111. J Child Adolesc Psychopharmacol. 2022. PMID: 35704877 Free PMC article. - Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder.
Dunlop BW, Li T, Kornstein SG, Friedman ES, Rothschild AJ, Pedersen R, Ninan P, Keller M, Trivedi MH. Dunlop BW, et al. J Psychiatr Res. 2011 Jan;45(1):96-103. doi: 10.1016/j.jpsychires.2010.04.032. Epub 2010 Jun 2. J Psychiatr Res. 2011. PMID: 20537348 Free PMC article. - Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression.
Turkoz I, Fu DJ, Bossie CA, Sheehan JJ, Alphs L. Turkoz I, et al. J Affect Disord. 2013 Aug 15;150(1):17-22. doi: 10.1016/j.jad.2013.01.047. Epub 2013 Mar 18. J Affect Disord. 2013. PMID: 23517884 Review. - Novel Augmentation Strategies in Major Depression.
Martiny K. Martiny K. Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
Cited by
- Readiness for treatment predicts depression outcomes in a partial hospital program.
McCarthy JM, Hudson JI, Carol EE, Kuller AM, Ramadurai R, Björgvinsson T, Beard C. McCarthy JM, et al. Psychol Serv. 2024 Nov;21(4):947-953. doi: 10.1037/ser0000835. Epub 2024 Jan 11. Psychol Serv. 2024. PMID: 38206859 - The effectiveness of antidepressant monotherapy in a naturalistic outpatient setting.
Lee TS, Nkouibert Assam P, Gersing KR, Chan E, Burchett BM, Sim K, Feng L, Krishnan KR, Rush AJ. Lee TS, et al. Prim Care Companion CNS Disord. 2012;14(5):PCC.12m01364. doi: 10.4088/PCC.12m01364. Epub 2012 Oct 4. Prim Care Companion CNS Disord. 2012. PMID: 23469327 Free PMC article. - Interpretation of health-related quality of life outcomes in Parkinson's disease from the EARLYSTIM Study.
Martinez-Martin P, Deuschl G, Tonder L, Schnitzler A, Houeto JL, Timmermann L, Rau J, Schade-Brittinger C, Stoker V, Vidailhet M, Krack P; EARLYSTIM Study Group. Martinez-Martin P, et al. PLoS One. 2020 Aug 21;15(8):e0237498. doi: 10.1371/journal.pone.0237498. eCollection 2020. PLoS One. 2020. PMID: 32822437 Free PMC article. - Etomidate versus Propofol for Electroconvulsive Therapy in Patients with Major Depressive Disorders in Terms of Clinical Responses to Treatment: A Retrospective Analysis.
Yoon IY, Ryu JH, Do SH, Min B, Koo CH. Yoon IY, et al. Brain Sci. 2023 Jul 3;13(7):1023. doi: 10.3390/brainsci13071023. Brain Sci. 2023. PMID: 37508956 Free PMC article. - Smartphone, Social Media, and Mental Health App Use in an Acute Transdiagnostic Psychiatric Sample.
Beard C, Silverman AL, Forgeard M, Wilmer MT, Torous J, Björgvinsson T. Beard C, et al. JMIR Mhealth Uhealth. 2019 Jun 7;7(6):e13364. doi: 10.2196/13364. JMIR Mhealth Uhealth. 2019. PMID: 31199338 Free PMC article.
References
- Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Department of Health, Education, and Welfare; 1976.
- Hsieh MH, Lin WW, Chen ST, Chen KC, Chen KP, Chiu NY, Huang C, Chang CJ, Lin CH, Lai TJ. A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting. Ann Gen Psychiatry. 2010;9:35. doi: 10.1186/1744-859X-9-35. - DOI - PMC - PubMed
- Beck AT, Steer RA. Beck Depression Inventory. San Antonio: The Psychological Corporation Inc; 1987.
- Hamilton M. Development of a rating scale for primary depressive illness. British journal of social and clinical psychology. 1967;6:278–296. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials